25 XP   0   0   10

North China Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse North China Pharmaceutical Co Ltd together

PenkeI guess you are interested in North China Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of North China Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about North China Pharmaceutical Co Ltd

I send you an email if I find something interesting about North China Pharmaceutical Co Ltd.

Quick analysis of North China Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of North China Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.65
Expected worth in 1 year
¥3.68
How sure are you?
97.4%

+ What do you gain per year?

Total Gains per Share
¥0.33
Return On Investment
7.0%

For what price can you sell your share?

Current Price per Share
¥4.62
Expected price per share
¥3.83 - ¥5.03
How sure are you?
50%

1. Valuation of North China Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥4.62

Intrinsic Value Per Share

¥16.89 - ¥20.23

Total Value Per Share

¥20.54 - ¥23.89

2. Growth of North China Pharmaceutical Co Ltd (5 min.)




Is North China Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$865.3m$937.5m-$74.2m-8.6%

How much money is North China Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$168.7k-$23.7m$23.9m14,193.7%
Net Profit Margin0.0%-6.6%--

How much money comes from the company's main activities?

3. Financial Health of North China Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of North China Pharmaceutical Co Ltd? (5 min.)

Welcome investor! North China Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of North China Pharmaceutical Co Ltd.

What can you expect buying and holding a share of North China Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of North China Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of North China Pharmaceutical Co Ltd is ¥4.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of North China Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in North China Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.65. Based on the TTM, the Book Value Change Per Share is ¥0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of North China Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%-0.01-0.3%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.02-0.3%0.000.1%0.000.1%
Usd Dividend Per Share0.010.3%0.010.2%0.010.3%0.010.3%0.020.3%
Usd Total Gains Per Share0.010.3%0.010.2%0.000.0%0.020.4%0.020.4%
Usd Price Per Share0.79-0.79-0.92-1.09-0.98-
Price to Earnings Ratio-105.92-545.37-209.56-467.87-301.49-
Price-to-Total Gains Ratio62.77-73.80-53.35-70.51-77.15-
Price to Book Ratio1.56-1.57-1.69-2.13-2.09-
Price-to-Total Gains Ratio62.77-73.80-53.35-70.51-77.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.63756
Number of shares1568
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.010.02
Gains per Quarter (1568 shares)17.6025.40
Gains per Year (1568 shares)70.41101.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
165560821992
21301113016538194
31951620024757296
42602127033077398
53262734041296500
639132410495115602
745637480577134704
852142550660153806
958648620742172908
10651536908251911010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%31.04.04.079.5%70.04.012.081.4%
Book Value Change Per Share4.00.00.0100.0%7.05.00.058.3%15.05.00.075.0%27.012.00.069.2%57.029.00.066.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%68.00.018.079.1%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%38.01.00.097.4%78.08.00.090.7%

Fundamentals of North China Pharmaceutical Co Ltd

About North China Pharmaceutical Co Ltd

North China Pharmaceutical Company.Ltd operates as a chemical pharmaceutical company in China. It primarily offers anti-infective drugs; biotechnology drugs; cardiovascular cerebrovascular; immunomodulators; vitamins health consumer products; and bio-agricultural and veterinary drugs. The company was founded in 1953 and is based in Shijiazhuang, China.

Fundamental data was last updated by Penke on 2024-04-17 10:33:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of North China Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit North China Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1.1% means that ¥-0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of North China Pharmaceutical Co Ltd:

  • The MRQ is -1.1%. The company is making a loss. -1
  • The TTM is 0.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM0.0%-1.1%
TTM0.0%YOY-6.6%+6.6%
TTM0.0%5Y-0.8%+0.8%
5Y-0.8%10Y0.0%-0.8%
1.1.2. Return on Assets

Shows how efficient North China Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.1% Return on Assets means that North China Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of North China Pharmaceutical Co Ltd:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM0.0%-0.1%
TTM0.0%YOY-0.8%+0.8%
TTM0.0%5Y-0.1%+0.1%
5Y-0.1%10Y0.0%-0.1%
1.1.3. Return on Equity

Shows how efficient North China Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.4% Return on Equity means North China Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of North China Pharmaceutical Co Ltd:

  • The MRQ is -0.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.4%TTM0.0%-0.5%
TTM0.0%YOY-3.3%+3.3%
TTM0.0%5Y-0.4%+0.4%
5Y-0.4%10Y0.0%-0.4%

1.2. Operating Efficiency of North China Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient North China Pharmaceutical Co Ltd is operating .

  • Measures how much profit North China Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of North China Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.9%-2.9%
TTM2.9%YOY5.9%-3.1%
TTM2.9%5Y5.8%-2.9%
5Y5.8%10Y3.4%+2.5%
1.2.2. Operating Ratio

Measures how efficient North China Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.63 means that the operating costs are ¥1.63 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of North China Pharmaceutical Co Ltd:

  • The MRQ is 1.626. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.621. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.626TTM1.621+0.004
TTM1.621YOY1.592+0.029
TTM1.6215Y1.573+0.048
5Y1.57310Y1.226+0.347

1.3. Liquidity of North China Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if North China Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.78 means the company has ¥0.78 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of North China Pharmaceutical Co Ltd:

  • The MRQ is 0.781. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.798. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.781TTM0.798-0.017
TTM0.798YOY0.806-0.008
TTM0.7985Y0.844-0.046
5Y0.84410Y0.487+0.357
1.3.2. Quick Ratio

Measures if North China Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.19 means the company can pay off ¥0.19 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of North China Pharmaceutical Co Ltd:

  • The MRQ is 0.188. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.295. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.188TTM0.295-0.107
TTM0.295YOY0.300-0.005
TTM0.2955Y0.305-0.009
5Y0.30510Y0.347-0.042

1.4. Solvency of North China Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of North China Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare North China Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.70 means that North China Pharmaceutical Co Ltd assets are financed with 70.1% credit (debt) and the remaining percentage (100% - 70.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of North China Pharmaceutical Co Ltd:

  • The MRQ is 0.701. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.707. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.701TTM0.707-0.006
TTM0.707YOY0.713-0.006
TTM0.7075Y0.711-0.004
5Y0.71110Y0.696+0.014
1.4.2. Debt to Equity Ratio

Measures if North China Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 276.3% means that company has ¥2.76 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of North China Pharmaceutical Co Ltd:

  • The MRQ is 2.763. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.837. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.763TTM2.837-0.074
TTM2.837YOY2.883-0.045
TTM2.8375Y2.749+0.088
5Y2.74910Y2.458+0.291

2. Market Valuation of North China Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings North China Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare North China Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -105.92 means the investor is paying ¥-105.92 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of North China Pharmaceutical Co Ltd:

  • The EOD is -85.851. Based on the earnings, the company is expensive. -2
  • The MRQ is -105.920. Based on the earnings, the company is expensive. -2
  • The TTM is 545.373. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-85.851MRQ-105.920+20.069
MRQ-105.920TTM545.373-651.293
TTM545.373YOY209.560+335.813
TTM545.3735Y467.874+77.499
5Y467.87410Y301.489+166.384
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of North China Pharmaceutical Co Ltd:

  • The EOD is 10.561. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.030. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.782. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.561MRQ13.030-2.469
MRQ13.030TTM5.782+7.248
TTM5.782YOY3.069+2.713
TTM5.7825Y16.340-10.558
5Y16.34010Y-12.533+28.873
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of North China Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of North China Pharmaceutical Co Ltd:

  • The EOD is 1.264. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.560. Based on the equity, the company is underpriced. +1
  • The TTM is 1.572. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.264MRQ1.560-0.296
MRQ1.560TTM1.572-0.013
TTM1.572YOY1.687-0.114
TTM1.5725Y2.128-0.556
5Y2.12810Y2.090+0.038
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of North China Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0040.006-33%-0.115+2899%0.022-81%0.032-87%
Book Value Per Share--3.6553.646+0%3.960-8%3.717-2%3.390+8%
Current Ratio--0.7810.798-2%0.806-3%0.844-7%0.487+60%
Debt To Asset Ratio--0.7010.707-1%0.713-2%0.711-1%0.696+1%
Debt To Equity Ratio--2.7632.837-3%2.883-4%2.749+0%2.458+12%
Dividend Per Share--0.0870.075+15%0.108-20%0.095-9%0.116-25%
Eps---0.0130.001-1988%-0.100+646%-0.012-10%-0.001-93%
Free Cash Flow Per Share--0.1090.058+87%0.066+65%0.035+215%0.006+1761%
Free Cash Flow To Equity Per Share--0.1090.049+125%-0.537+591%0.017+535%0.033+234%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.897+11%
Intrinsic Value_10Y_max--20.234--------
Intrinsic Value_10Y_min--16.889--------
Intrinsic Value_1Y_max--0.520--------
Intrinsic Value_1Y_min--0.510--------
Intrinsic Value_3Y_max--2.711--------
Intrinsic Value_3Y_min--2.565--------
Intrinsic Value_5Y_max--6.288--------
Intrinsic Value_5Y_min--5.737--------
Market Cap7926672821.760-23%9779663109.0009835424346.025-1%11448210893.825-15%13563705330.745-28%12181132899.902-20%
Net Profit Margin---0.0110.000-468357%-0.066+510%-0.008-24%0.000-5575%
Operating Margin---0.029-100%0.059-100%0.058-100%0.034-100%
Operating Ratio--1.6261.621+0%1.592+2%1.573+3%1.226+33%
Pb Ratio1.264-23%1.5601.572-1%1.687-8%2.128-27%2.090-25%
Pe Ratio-85.851+19%-105.920545.373-119%209.560-151%467.874-123%301.489-135%
Price Per Share4.620-23%5.7005.733-1%6.673-15%7.906-28%7.093-20%
Price To Free Cash Flow Ratio10.561-23%13.0305.782+125%3.069+325%16.340-20%-12.533+196%
Price To Total Gains Ratio50.876-23%62.77073.797-15%53.354+18%70.511-11%77.149-19%
Quick Ratio--0.1880.295-36%0.300-37%0.305-38%0.347-46%
Return On Assets---0.0010.000-2160%-0.008+643%-0.001-15%0.000-1992%
Return On Equity---0.0040.000-2006%-0.033+654%-0.004-6%0.000-91%
Total Gains Per Share--0.0910.081+12%-0.007+108%0.117-23%0.148-38%
Usd Book Value--865316604.714863326103.025+0%937546348.790-8%879959372.869-2%803672479.963+8%
Usd Book Value Change Per Share--0.0010.001-33%-0.016+2899%0.003-81%0.004-87%
Usd Book Value Per Share--0.5040.503+0%0.546-8%0.513-2%0.468+8%
Usd Dividend Per Share--0.0120.010+15%0.015-20%0.013-9%0.016-25%
Usd Eps---0.0020.000-1988%-0.014+646%-0.002-10%0.000-93%
Usd Free Cash Flow--25893866.67613842487.062+87%15690828.948+65%8218614.773+215%1189782.379+2076%
Usd Free Cash Flow Per Share--0.0150.008+87%0.009+65%0.005+215%0.001+1761%
Usd Free Cash Flow To Equity Per Share--0.0150.007+125%-0.074+591%0.002+535%0.005+234%
Usd Market Cap1093880849.403-23%1349593509.0421357288559.751-1%1579853103.348-15%1871791335.643-28%1680996340.186-20%
Usd Price Per Share0.638-23%0.7870.791-1%0.921-15%1.091-28%0.979-20%
Usd Profit---3185419.014168716.979-1988%-23778486.750+646%-2862428.101-10%-230911.983-93%
Usd Revenue--296081800.302349146947.777-15%362248173.766-18%368308170.322-20%329249040.774-10%
Usd Total Gains Per Share--0.0130.011+12%-0.001+108%0.016-23%0.020-38%
 EOD+3 -5MRQTTM+17 -18YOY+21 -145Y+10 -2510Y+13 -23

3.2. Fundamental Score

Let's check the fundamental score of North China Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-85.851
Price to Book Ratio (EOD)Between0-11.264
Net Profit Margin (MRQ)Greater than0-0.011
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.188
Current Ratio (MRQ)Greater than10.781
Debt to Asset Ratio (MRQ)Less than10.701
Debt to Equity Ratio (MRQ)Less than12.763
Return on Equity (MRQ)Greater than0.15-0.004
Return on Assets (MRQ)Greater than0.05-0.001
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of North China Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.225
Ma 20Greater thanMa 504.652
Ma 50Greater thanMa 1004.735
Ma 100Greater thanMa 2005.174
OpenGreater thanClose4.590
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets20,956,700
Total Liabilities14,686,290
Total Stockholder Equity5,315,304
 As reported
Total Liabilities 14,686,290
Total Stockholder Equity+ 5,315,304
Total Assets = 20,956,700

Assets

Total Assets20,956,700
Total Current Assets8,017,591
Long-term Assets12,939,109
Total Current Assets
Cash And Cash Equivalents 988,276
Net Receivables 1,930,903
Inventory 2,607,784
Other Current Assets 170,621
Total Current Assets  (as reported)8,017,591
Total Current Assets  (calculated)5,697,584
+/- 2,320,007
Long-term Assets
Property Plant Equipment 7,531,773
Goodwill 3,337
Intangible Assets 4,079,029
Long-term Assets  (as reported)12,939,109
Long-term Assets  (calculated)11,614,138
+/- 1,324,971

Liabilities & Shareholders' Equity

Total Current Liabilities10,268,565
Long-term Liabilities4,417,725
Total Stockholder Equity5,315,304
Total Current Liabilities
Short Long Term Debt 5,467,710
Accounts payable 2,489,895
Other Current Liabilities 1,865
Total Current Liabilities  (as reported)10,268,565
Total Current Liabilities  (calculated)7,959,469
+/- 2,309,096
Long-term Liabilities
Long term Debt 4,080,858
Capital Lease Obligations Min Short Term Debt299,161
Long-term Liabilities  (as reported)4,417,725
Long-term Liabilities  (calculated)4,380,019
+/- 37,705
Total Stockholder Equity
Total Stockholder Equity (as reported)5,315,304
Total Stockholder Equity (calculated)0
+/- 5,315,304
Other
Capital Stock1,715,730
Common Stock Shares Outstanding 1,715,730
Net Debt 8,560,292
Net Invested Capital 14,863,872
Net Working Capital -2,250,974
Property Plant and Equipment Gross 7,531,773



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
5,788,664
5,971,116
6,121,118
7,335,090
7,309,603
7,326,407
7,259,496
6,958,987
7,094,249
7,242,241
7,143,604
7,264,605
7,377,642
7,622,280
7,705,335
7,611,586
7,432,417
7,580,911
7,224,887
7,005,176
7,092,847
7,079,149
7,224,063
7,004,947
6,998,048
7,045,265
7,139,422
6,671,836
6,843,026
7,032,099
7,445,328
7,037,588
7,106,232
7,660,870
6,739,815
7,300,959
8,253,184
8,764,195
9,201,800
9,120,361
9,429,974
10,359,046
11,283,953
11,266,715
11,664,917
12,508,293
12,278,566
13,540,908
14,122,914
13,902,492
14,099,923
14,560,088
14,882,685
15,315,037
14,826,694
15,564,082
15,652,896
15,842,816
16,234,220
15,997,230
16,329,244
16,325,802
16,206,493
16,476,254
17,089,035
16,807,548
17,339,261
17,151,500
17,165,902
17,227,824
17,923,523
17,916,817
18,298,790
18,308,557
18,458,796
18,541,191
20,971,440
20,586,686
21,752,325
23,931,717
24,744,559
25,539,582
25,598,268
24,929,935
25,158,030
25,293,354
23,156,853
21,221,018
21,819,916
21,113,767
21,508,962
20,956,700
20,956,70021,508,96221,113,76721,819,91621,221,01823,156,85325,293,35425,158,03024,929,93525,598,26825,539,58224,744,55923,931,71721,752,32520,586,68620,971,44018,541,19118,458,79618,308,55718,298,79017,916,81717,923,52317,227,82417,165,90217,151,50017,339,26116,807,54817,089,03516,476,25416,206,49316,325,80216,329,24415,997,23016,234,22015,842,81615,652,89615,564,08214,826,69415,315,03714,882,68514,560,08814,099,92313,902,49214,122,91413,540,90812,278,56612,508,29311,664,91711,266,71511,283,95310,359,0469,429,9749,120,3619,201,8008,764,1958,253,1847,300,9596,739,8157,660,8707,106,2327,037,5887,445,3287,032,0996,843,0266,671,8367,139,4227,045,2656,998,0487,004,9477,224,0637,079,1497,092,8477,005,1767,224,8877,580,9117,432,4177,611,5867,705,3357,622,2807,377,6427,264,6057,143,6047,242,2417,094,2496,958,9877,259,4967,326,4077,309,6037,335,0906,121,1185,971,1165,788,664
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,895,382
7,472,970
7,357,961
7,734,102
7,648,373
7,754,911
7,786,771
10,222,791
9,761,778
10,765,307
12,111,289
12,920,656
13,454,870
13,513,908
12,712,196
12,966,054
13,157,161
10,948,564
8,982,899
9,624,209
8,948,204
9,084,512
8,017,591
8,017,5919,084,5128,948,2049,624,2098,982,89910,948,56413,157,16112,966,05412,712,19613,513,90813,454,87012,920,65612,111,28910,765,3079,761,77810,222,7917,786,7717,754,9117,648,3737,734,1027,357,9617,472,9706,895,382000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
864,655
1,401,444
1,249,546
1,593,688
1,301,418
1,341,244
1,222,873
3,363,792
2,897,977
3,645,184
4,907,511
5,382,158
5,753,391
5,845,975
5,304,983
5,029,321
4,865,771
2,696,142
1,682,737
1,948,713
1,387,912
1,484,265
988,276
988,2761,484,2651,387,9121,948,7131,682,7372,696,1424,865,7715,029,3215,304,9835,845,9755,753,3915,382,1584,907,5113,645,1842,897,9773,363,7921,222,8731,341,2441,301,4181,593,6881,249,5461,401,444864,655000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
2,521,613
2,616,647
2,693,511
3,170,609
3,215,045
3,231,574
3,148,815
2,631,053
2,852,308
2,944,629
2,959,045
2,763,032
2,859,104
2,897,887
2,837,634
2,286,931
2,249,042
2,256,535
2,256,605
1,979,809
2,104,828
2,237,527
2,110,190
1,936,131
1,901,584
1,893,689
1,914,490
1,570,062
1,379,296
1,577,131
1,624,165
1,325,056
1,406,987
1,420,001
1,120,016
1,013,318
1,401,597
1,744,763
1,876,096
1,666,201
1,571,125
1,588,359
1,724,636
1,676,405
2,013,127
1,860,991
1,708,973
2,055,354
2,044,067
2,124,012
2,294,384
2,848,075
2,924,113
2,920,569
2,717,927
2,639,363
2,824,854
2,850,222
2,841,325
3,338,963
3,580,623
3,642,158
3,709,985
3,684,948
3,951,996
3,885,591
3,953,353
3,687,456
3,876,600
3,917,550
3,807,977
3,806,844
1,288,742
1,414,258
1,377,090
4,192,248
4,229,316
4,521,662
4,542,094
4,434,662
4,740,516
4,914,666
4,775,957
4,590,574
5,042,342
2,403,997
5,062,595
4,334,597
4,606,713
4,549,491
2,305,695
1,930,903
1,930,9032,305,6954,549,4914,606,7134,334,5975,062,5952,403,9975,042,3424,590,5744,775,9574,914,6664,740,5164,434,6624,542,0944,521,6624,229,3164,192,2481,377,0901,414,2581,288,7423,806,8443,807,9773,917,5503,876,6003,687,4563,953,3533,885,5913,951,9963,684,9483,709,9853,642,1583,580,6233,338,9632,841,3252,850,2222,824,8542,639,3632,717,9272,920,5692,924,1132,848,0752,294,3842,124,0122,044,0672,055,3541,708,9731,860,9912,013,1271,676,4051,724,6361,588,3591,571,1251,666,2011,876,0961,744,7631,401,5971,013,3181,120,0161,420,0011,406,9871,325,0561,624,1651,577,1311,379,2961,570,0621,914,4901,893,6891,901,5841,936,1312,110,1902,237,5272,104,8281,979,8092,256,6052,256,5352,249,0422,286,9312,837,6342,897,8872,859,1042,763,0322,959,0452,944,6292,852,3082,631,0533,148,8153,231,5743,215,0453,170,6092,693,5112,616,6472,521,613
       Other Current Assets 
128,854
156,787
35,218
103,971
106,599
104,430
86,106
53,854
43,140
55,629
44,175
74,902
39,239
119,600
116,290
100,047
91,013
97,054
93,500
81,316
100,209
112,832
128,757
87,158
125,531
138,996
148,119
175,761
431,490
203,291
221,897
209,256
193,769
221,978
322,860
189,785
282,273
123,332
395,075
140,319
200,268
163,533
228,310
191,143
275,702
199,018
213,093
214,802
339,484
256,275
246,405
193,835
218,175
312,218
321,995
274,653
376,363
384,064
400,510
239,726
265,213
281,637
350,861
232,039
318,625
274,813
389,603
251,829
331,723
243,582
348,861
227,894
162,086
166,298
179,650
262,343
455,510
292,984
461,272
316,193
414,842
367,572
584,465
424,730
455,730
219,880
486,226
442,263
503,174
496,105
185,772
170,621
170,621185,772496,105503,174442,263486,226219,880455,730424,730584,465367,572414,842316,193461,272292,984455,510262,343179,650166,298162,086227,894348,861243,582331,723251,829389,603274,813318,625232,039350,861281,637265,213239,726400,510384,064376,363274,653321,995312,218218,175193,835246,405256,275339,484214,802213,093199,018275,702191,143228,310163,533200,268140,319395,075123,332282,273189,785322,860221,978193,769209,256221,897203,291431,490175,761148,119138,996125,53187,158128,757112,832100,20981,31693,50097,05491,013100,047116,290119,60039,23974,90244,17555,62943,14053,85486,106104,430106,599103,97135,218156,787128,854
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,564,688
10,660,184
10,703,884
10,754,420
10,748,649
10,824,908
10,987,018
11,820,428
11,823,902
12,084,712
12,084,359
12,217,739
12,191,976
12,136,193
12,208,289
12,238,119
12,195,707
12,165,563
12,424,449
12,939,109
12,939,10912,424,44912,165,56312,195,70712,238,11912,208,28912,136,19312,191,97612,217,73912,084,35912,084,71211,823,90211,820,42810,987,01810,824,90810,748,64910,754,42010,703,88410,660,18410,564,688000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,888,489
1,866,788
1,810,754
2,473,698
2,441,554
2,444,973
2,493,099
2,520,214
2,529,649
2,582,615
2,630,890
2,799,447
2,860,764
2,907,048
2,886,384
3,086,947
3,047,754
3,162,137
3,000,905
3,107,528
2,936,111
3,024,816
3,041,321
3,270,976
2,996,017
2,970,063
2,959,775
3,065,207
2,843,010
3,011,134
2,797,530
2,990,034
2,804,481
3,070,984
2,692,476
3,121,358
3,097,133
3,801,462
3,847,538
4,666,603
4,875,787
5,464,566
5,982,916
6,038,950
6,076,645
6,706,317
6,964,474
7,680,589
7,703,155
8,097,130
7,992,592
8,258,638
8,060,133
8,384,258
8,108,421
8,474,848
8,033,084
8,134,554
8,312,137
8,143,208
8,197,267
8,199,462
8,217,395
8,338,862
8,313,330
8,299,343
8,346,709
8,497,082
8,406,652
8,388,794
8,484,828
8,433,709
8,447,509
8,383,333
8,404,870
8,297,229
8,287,117
8,189,626
8,316,424
8,443,938
8,455,486
8,326,219
8,311,860
8,309,961
8,223,740
0
8,082,991
7,928,035
7,817,613
7,692,738
7,577,328
7,531,773
7,531,7737,577,3287,692,7387,817,6137,928,0358,082,99108,223,7408,309,9618,311,8608,326,2198,455,4868,443,9388,316,4248,189,6268,287,1178,297,2298,404,8708,383,3338,447,5098,433,7098,484,8288,388,7948,406,6528,497,0828,346,7098,299,3438,313,3308,338,8628,217,3958,199,4628,197,2678,143,2088,312,1378,134,5548,033,0848,474,8488,108,4218,384,2588,060,1338,258,6387,992,5928,097,1307,703,1557,680,5896,964,4746,706,3176,076,6456,038,9505,982,9165,464,5664,875,7874,666,6033,847,5383,801,4623,097,1333,121,3582,692,4763,070,9842,804,4812,990,0342,797,5303,011,1342,843,0103,065,2072,959,7752,970,0632,996,0173,270,9763,041,3213,024,8162,936,1113,107,5283,000,9053,162,1373,047,7543,086,9472,886,3842,907,0482,860,7642,799,4472,630,8902,582,6152,529,6492,520,2142,493,0992,444,9732,441,5542,473,6981,810,7541,866,7881,888,489
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,337
3,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,33700000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
658,538
668,518
677,261
677,501
679,498
691,116
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000691,116679,498677,501677,261668,518658,538000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
109,896
109,928
111,393
118,483
115,193
116,468
114,100
110,566
113,360
110,526
108,411
106,700
109,648
108,515
107,473
119,762
124,967
54,112
119,448
56,194
106,653
59,097
202,389
56,194
205,629
208,909
261,610
59,547
248,818
59,474
251,471
52,968
268,272
73,374
290,746
67,755
329,203
74,384
346,065
66,797
351,235
60,953
376,216
58,767
406,000
53,226
439,946
51,376
527,817
46,351
575,542
70,798
622,519
65,937
693,806
712,691
320,405
316,484
309,551
355,148
350,095
352,490
347,798
351,665
346,407
342,322
338,667
339,738
353,789
354,870
371,899
375,982
1,341,506
1,119,189
1,502,026
1,585,618
1,638,092
1,755,872
1,834,595
2,624,005
2,682,761
2,766,617
2,822,030
2,956,410
3,005,543
3,037,554
3,113,289
3,279,058
3,336,983
3,420,429
3,527,424
4,079,029
4,079,0293,527,4243,420,4293,336,9833,279,0583,113,2893,037,5543,005,5432,956,4102,822,0302,766,6172,682,7612,624,0051,834,5951,755,8721,638,0921,585,6181,502,0261,119,1891,341,506375,982371,899354,870353,789339,738338,667342,322346,407351,665347,798352,490350,095355,148309,551316,484320,405712,691693,80665,937622,51970,798575,54246,351527,81751,376439,94653,226406,00058,767376,21660,953351,23566,797346,06574,384329,20367,755290,74673,374268,27252,968251,47159,474248,81859,547261,610208,909205,62956,194202,38959,097106,65356,194119,44854,112124,967119,762107,473108,515109,648106,700108,411110,526113,360110,566114,100116,468115,193118,483111,393109,928109,896
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,564,688
10,660,184
10,703,884
10,754,420
10,748,649
0
8,316,424
-59,327
0
-59,327
0
-58,831
0
0
0
0
0
0
0
0
00000000-58,8310-59,3270-59,3278,316,424010,748,64910,754,42010,703,88410,660,18410,564,688000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
3,068,438
3,267,563
3,388,800
4,634,147
4,551,314
4,544,281
4,425,890
4,291,189
4,329,937
4,473,410
4,357,536
4,509,310
4,585,909
4,872,483
4,951,981
5,891,758
5,728,984
5,868,290
5,588,511
5,547,080
5,636,170
5,668,241
5,853,353
5,614,817
5,479,022
5,526,619
5,587,426
5,216,068
5,375,967
5,500,357
5,843,927
5,367,195
5,422,236
6,064,913
6,030,945
6,410,042
7,185,240
7,620,327
8,036,617
7,938,664
8,234,507
9,154,129
10,078,189
9,952,791
10,375,663
11,250,757
11,054,463
9,362,770
9,940,728
9,764,500
9,955,882
10,414,214
10,730,994
10,094,393
9,594,619
10,317,786
10,394,293
10,578,344
10,947,069
10,727,502
11,046,439
11,058,610
10,904,427
11,184,975
11,775,275
11,510,651
12,053,579
11,870,927
11,862,874
11,905,007
12,497,183
12,404,784
12,758,601
12,765,953
12,896,626
12,917,137
15,288,657
14,862,192
15,194,743
16,876,151
17,740,470
18,537,473
18,579,995
17,912,704
18,119,821
18,347,726
16,193,809
14,992,642
15,585,240
14,858,274
15,245,597
14,686,290
14,686,29015,245,59714,858,27415,585,24014,992,64216,193,80918,347,72618,119,82117,912,70418,579,99518,537,47317,740,47016,876,15115,194,74314,862,19215,288,65712,917,13712,896,62612,765,95312,758,60112,404,78412,497,18311,905,00711,862,87411,870,92712,053,57911,510,65111,775,27511,184,97510,904,42711,058,61011,046,43910,727,50210,947,06910,578,34410,394,29310,317,7869,594,61910,094,39310,730,99410,414,2149,955,8829,764,5009,940,7289,362,77011,054,46311,250,75710,375,6639,952,79110,078,1899,154,1298,234,5077,938,6648,036,6177,620,3277,185,2406,410,0426,030,9456,064,9135,422,2365,367,1955,843,9275,500,3575,375,9675,216,0685,587,4265,526,6195,479,0225,614,8175,853,3535,668,2415,636,1705,547,0805,588,5115,868,2905,728,9845,891,7584,951,9814,872,4834,585,9094,509,3104,357,5364,473,4104,329,9374,291,1894,425,8904,544,2814,551,3144,634,1473,388,8003,267,5633,068,438
   > Total Current Liabilities 
1,909,195
2,146,463
2,204,762
3,963,827
3,889,194
3,861,261
3,696,870
4,066,032
3,856,281
4,034,774
3,775,200
4,436,595
4,506,814
4,831,637
4,754,735
5,146,362
4,983,537
5,123,394
4,852,216
5,505,059
5,574,149
5,605,620
5,790,625
5,552,718
5,431,922
5,473,809
5,533,567
5,189,006
5,344,216
5,476,163
5,803,372
5,343,563
5,288,604
5,768,704
5,225,911
4,495,565
4,639,610
4,771,307
5,188,227
4,832,734
4,938,464
5,476,838
6,022,505
6,392,031
6,686,842
7,204,869
7,697,183
5,690,191
5,880,503
5,892,853
6,106,624
7,092,968
8,053,782
7,989,010
7,916,349
8,785,965
8,045,894
7,923,972
7,837,179
7,878,547
8,351,244
8,052,544
8,061,012
9,106,781
10,402,807
9,872,237
9,444,890
8,695,175
8,831,414
9,755,288
10,383,353
10,707,619
11,006,329
10,635,930
10,404,310
10,080,409
11,889,108
11,047,380
11,254,495
11,753,326
13,253,750
13,917,970
14,143,440
14,239,895
14,673,292
15,341,482
14,446,957
12,409,219
12,378,136
11,017,795
11,051,381
10,268,565
10,268,56511,051,38111,017,79512,378,13612,409,21914,446,95715,341,48214,673,29214,239,89514,143,44013,917,97013,253,75011,753,32611,254,49511,047,38011,889,10810,080,40910,404,31010,635,93011,006,32910,707,61910,383,3539,755,2888,831,4148,695,1759,444,8909,872,23710,402,8079,106,7818,061,0128,052,5448,351,2447,878,5477,837,1797,923,9728,045,8948,785,9657,916,3497,989,0108,053,7827,092,9686,106,6245,892,8535,880,5035,690,1917,697,1837,204,8696,686,8426,392,0316,022,5055,476,8384,938,4644,832,7345,188,2274,771,3074,639,6104,495,5655,225,9115,768,7045,288,6045,343,5635,803,3725,476,1635,344,2165,189,0065,533,5675,473,8095,431,9225,552,7185,790,6255,605,6205,574,1495,505,0594,852,2165,123,3944,983,5375,146,3624,754,7354,831,6374,506,8144,436,5953,775,2004,034,7743,856,2814,066,0323,696,8703,861,2613,889,1943,963,8272,204,7622,146,4631,909,195
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,636,190
1,535,451
1,738,502
5,089,725
5,093,733
5,486,275
6,280,168
8,009,255
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000008,009,2556,280,1685,486,2755,093,7335,089,7251,738,5021,535,4511,636,190000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,636,190
1,535,451
1,738,502
5,089,725
5,093,733
5,486,275
6,280,168
8,009,255
7,211,496
6,668,432
6,825,625
7,472,550
7,689,335
7,946,688
7,626,525
8,021,416
7,705,606
6,335,765
5,276,064
5,443,625
5,573,087
5,657,674
5,467,710
5,467,7105,657,6745,573,0875,443,6255,276,0646,335,7657,705,6068,021,4167,626,5257,946,6887,689,3357,472,5506,825,6256,668,4327,211,4968,009,2556,280,1685,486,2755,093,7335,089,7251,738,5021,535,4511,636,190000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
402,542
312,347
218,229
660,881
762,241
691,458
637,317
693,626
690,508
717,173
709,504
901,959
864,787
1,053,840
1,059,242
1,218,110
1,105,479
1,014,438
1,000,918
1,046,165
1,098,807
1,103,345
1,166,057
1,115,819
1,101,168
1,171,245
1,199,152
1,008,509
639,551
873,628
935,548
924,949
1,080,078
1,088,917
1,008,731
921,394
1,137,788
1,555,307
1,497,924
1,130,300
1,251,554
1,519,514
1,987,582
2,064,328
2,150,433
2,068,606
2,025,924
2,234,693
2,246,645
2,259,746
2,096,527
2,495,302
2,443,982
2,498,412
2,307,692
2,714,885
2,660,383
2,690,958
2,626,989
2,538,621
2,397,312
2,231,412
2,356,684
2,178,749
2,316,062
2,135,315
2,170,123
1,999,570
2,101,907
2,500,477
2,436,778
2,508,391
2,452,740
2,832,890
2,682,634
2,597,041
2,300,524
2,020,223
2,244,345
2,600,471
2,722,108
3,094,457
3,045,476
2,891,148
3,224,399
3,376,506
3,319,716
2,782,633
2,886,402
2,367,200
2,518,152
2,489,895
2,489,8952,518,1522,367,2002,886,4022,782,6333,319,7163,376,5063,224,3992,891,1483,045,4763,094,4572,722,1082,600,4712,244,3452,020,2232,300,5242,597,0412,682,6342,832,8902,452,7402,508,3912,436,7782,500,4772,101,9071,999,5702,170,1232,135,3152,316,0622,178,7492,356,6842,231,4122,397,3122,538,6212,626,9892,690,9582,660,3832,714,8852,307,6922,498,4122,443,9822,495,3022,096,5272,259,7462,246,6452,234,6932,025,9242,068,6062,150,4332,064,3281,987,5821,519,5141,251,5541,130,3001,497,9241,555,3071,137,788921,3941,008,7311,088,9171,080,078924,949935,548873,628639,5511,008,5091,199,1521,171,2451,101,1681,115,8191,166,0571,103,3451,098,8071,046,1651,000,9181,014,4381,105,4791,218,1101,059,2421,053,840864,787901,959709,504717,173690,508693,626637,317691,458762,241660,881218,229312,347402,542
       Other Current Liabilities 
310,073
465,299
561,953
704,666
586,673
645,023
578,453
399,306
423,243
610,121
537,466
433,186
447,117
481,675
419,371
629,160
572,068
541,406
544,198
433,944
449,712
437,120
418,973
515,184
534,719
556,274
677,067
599,615
1,109,125
1,008,185
1,102,904
742,062
845,917
1,276,342
1,460,256
568,741
623,392
652,570
688,913
579,047
510,871
528,296
533,066
704,110
783,405
776,667
783,178
888,619
938,508
1,000,090
981,266
1,143,389
2,095,389
2,062,135
2,117,787
2,113,068
2,007,814
1,252,086
1,147,849
1,124,473
4,650,386
757,650
557,172
636,533
647,912
686,789
737,599
831,085
2,093,583
736,298
1,309,473
589,779
2,725,213
2,010,218
1,567,605
644,302
597,103
499,935
618,673
715,206
823,037
625,965
703,418
972,344
891,414
7,542
967,518
960,177
992,183
818,713
15,385
1,865
1,86515,385818,713992,183960,177967,5187,542891,414972,344703,418625,965823,037715,206618,673499,935597,103644,3021,567,6052,010,2182,725,213589,7791,309,473736,2982,093,583831,085737,599686,789647,912636,533557,172757,6504,650,3861,124,4731,147,8491,252,0862,007,8142,113,0682,117,7872,062,1352,095,3891,143,389981,2661,000,090938,508888,619783,178776,667783,405704,110533,066528,296510,871579,047688,913652,570623,392568,7411,460,2561,276,342845,917742,0621,102,9041,008,1851,109,125599,615677,067556,274534,719515,184418,973437,120449,712433,944544,198541,406572,068629,160419,371481,675447,117433,186537,466610,121423,243399,306578,453645,023586,673704,666561,953465,299310,073
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,752,272
2,130,023
2,492,316
2,836,728
3,399,549
3,814,812
3,940,248
5,122,825
4,486,720
4,619,503
4,436,555
3,672,809
3,446,529
3,006,244
1,746,852
2,583,423
3,207,103
3,840,479
4,194,217
4,417,725
4,417,7254,194,2173,840,4793,207,1032,583,4231,746,8523,006,2443,446,5293,672,8094,436,5554,619,5034,486,7205,122,8253,940,2483,814,8123,399,5492,836,7282,492,3162,130,0231,752,272000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,636,190
-1,535,451
-1,738,502
-5,089,725
-5,093,733
-5,486,275
-6,280,168
-8,009,255
0
0
0
371,334
638,793
530,848
326,737
550,594
451,935
405,296
413,391
360,076
394,888
362,108
299,161
299,161362,108394,888360,076413,391405,296451,935550,594326,737530,848638,793371,334000-8,009,255-6,280,168-5,486,275-5,093,733-5,089,725-1,738,502-1,535,451-1,636,190000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,381,300
1,360,616
2,940
2,940
2,940
2,940
2,940
0
900
0
900
0
900
0
0
0
0
0
0
0
00000009000900090002,9402,9402,9402,9402,9401,360,6161,381,300000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
828,800
882,912
969,981
1,024,907
1,102,297
1,185,752
1,178,758
1,209,538
1,295,320
1,389,296
1,434,057
1,483,882
1,557,117
1,617,756
1,639,017
1,493,093
0
1,628,763
1,688,169
1,738,003
0
0
0
0001,738,0031,688,1691,628,76301,493,0931,639,0171,617,7561,557,1171,483,8821,434,0571,389,2961,295,3201,209,5381,178,7581,185,7521,102,2971,024,907969,981882,912828,800000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
2,546,917
2,527,735
2,546,136
2,439,907
2,484,662
2,526,577
2,558,431
2,450,152
2,531,224
2,528,876
2,538,223
2,508,237
2,541,956
2,501,368
2,502,069
1,518,961
1,502,637
1,512,523
1,433,009
1,254,536
1,253,801
1,205,485
1,160,285
1,178,226
1,289,984
1,288,754
1,320,130
1,246,477
1,255,819
1,322,987
1,391,236
1,462,317
1,478,919
1,393,071
624,055
797,261
905,740
976,369
994,438
1,018,381
1,026,867
1,030,803
1,034,839
1,145,133
1,120,542
1,090,305
1,064,716
4,072,222
4,077,059
4,029,232
4,037,687
4,039,126
4,045,610
5,169,310
5,181,476
5,203,653
5,221,177
5,233,174
5,256,509
5,288,412
5,301,991
5,287,221
5,322,233
5,312,747
5,336,308
5,319,887
5,309,269
5,306,362
5,330,526
5,352,581
5,369,949
5,442,465
5,471,871
5,473,736
5,497,118
5,560,029
5,624,144
5,624,068
5,639,237
6,124,327
6,069,488
6,077,017
6,096,619
6,085,481
6,100,944
6,020,432
6,032,136
5,300,125
5,305,300
5,328,627
5,330,346
5,315,304
5,315,3045,330,3465,328,6275,305,3005,300,1256,032,1366,020,4326,100,9446,085,4816,096,6196,077,0176,069,4886,124,3275,639,2375,624,0685,624,1445,560,0295,497,1185,473,7365,471,8715,442,4655,369,9495,352,5815,330,5265,306,3625,309,2695,319,8875,336,3085,312,7475,322,2335,287,2215,301,9915,288,4125,256,5095,233,1745,221,1775,203,6535,181,4765,169,3104,045,6104,039,1264,037,6874,029,2324,077,0594,072,2221,064,7161,090,3051,120,5421,145,1331,034,8391,030,8031,026,8671,018,381994,438976,369905,740797,261624,0551,393,0711,478,9191,462,3171,391,2361,322,9871,255,8191,246,4771,320,1301,288,7541,289,9841,178,2261,160,2851,205,4851,253,8011,254,5361,433,0091,512,5231,502,6371,518,9612,502,0692,501,3682,541,9562,508,2372,538,2232,528,8762,531,2242,450,1522,558,4312,526,5772,484,6622,439,9072,546,1362,527,7352,546,917
   Common Stock
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
1,169,394
761,909
761,909
761,909
761,909
761,909
761,909
761,909
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,028,578
1,378,578
1,378,578
1,378,578
1,378,578
1,378,578
1,378,578
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,630,805
1,715,730
1,715,730
1,715,730
1,715,730
0
1,715,730
1,715,730
1,715,730
0
0
0
0001,715,7301,715,7301,715,73001,715,7301,715,7301,715,7301,715,7301,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,630,8051,378,5781,378,5781,378,5781,378,5781,378,5781,378,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,5781,028,578761,909761,909761,909761,909761,909761,909761,9091,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,3941,169,394
   Retained Earnings 
107,890
68,418
98,051
0
0
2,233
34,083
0
0
69,599
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,092
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,425
152,213
149,391
180,594
194,473
178,097
212,733
202,393
215,883
200,569
191,489
188,536
214,979
234,017
249,160
322,875
117,322
117,471
129,578
427,841
490,814
488,345
507,006
510,194
452,994
462,266
479,039
480,679
494,361
117,916
415,671
-311,496
-306,076
-579,958
-578,530
-629,042
-629,042-578,530-579,958-306,076-311,496415,671117,916494,361480,679479,039462,266452,994510,194507,006488,345490,814427,841129,578117,471117,322322,875249,160234,017214,979188,536191,489200,569215,883202,393212,733178,097194,473180,594149,391152,213139,42500000000000000000000007,0920000000000000000000000069,5990034,0832,2330098,05168,418107,890
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,729
8,954
7,754
6,366
8,082
9,357
10,352
11,494
13,887
10,395
5,773
8,135
6,391
9,220
2,937
3,986
0
14,600
9,504
9,258
11,459
0
0
0011,4599,2589,50414,60003,9862,9379,2206,3918,1355,77310,39513,88711,49410,3529,3578,0826,3667,7548,9546,729000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue10,120,201
Cost of Revenue-6,883,614
Gross Profit3,236,5883,236,588
 
Operating Income (+$)
Gross Profit3,236,588
Operating Expense-9,523,463
Operating Income596,739-6,286,875
 
Operating Expense (+$)
Research Development297,200
Selling General Administrative1,913,121
Selling And Marketing Expenses0
Operating Expense9,523,4632,210,321
 
Net Interest Income (+$)
Interest Income27,666
Interest Expense-501,896
Other Finance Cost-10,005
Net Interest Income-484,235
 
Pretax Income (+$)
Operating Income596,739
Net Interest Income-484,235
Other Non-Operating Income Expenses0
Income Before Tax (EBT)158,536596,739
EBIT - interestExpense = -501,896
4,890
506,786
Interest Expense501,896
Earnings Before Interest and Taxes (EBIT)0660,431
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax158,536
Tax Provision-109,148
Net Income From Continuing Ops49,38849,388
Net Income4,890
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0484,235
 

Technical Analysis of North China Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of North China Pharmaceutical Co Ltd. The general trend of North China Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine North China Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of North China Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 4.62 < 4.62 < 5.03.

The bearish price targets are: 4.36 > 3.83.

Tweet this
North China Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of North China Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

North China Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of North China Pharmaceutical Co Ltd. The current macd is -0.07512116.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the North China Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for North China Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the North China Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
North China Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNorth China Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of North China Pharmaceutical Co Ltd. The current adx is 25.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell North China Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
North China Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of North China Pharmaceutical Co Ltd. The current sar is 4.74913105.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
North China Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of North China Pharmaceutical Co Ltd. The current rsi is 47.23. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
North China Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartNorth China Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of North China Pharmaceutical Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the North China Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
North China Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartNorth China Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of North China Pharmaceutical Co Ltd. The current cci is -49.67187146.

North China Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartNorth China Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of North China Pharmaceutical Co Ltd. The current cmo is -1.02509408.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
North China Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNorth China Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of North China Pharmaceutical Co Ltd. The current willr is -46.93877551.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that North China Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
North China Pharmaceutical Co Ltd Daily Williams %R ChartNorth China Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of North China Pharmaceutical Co Ltd.

North China Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of North China Pharmaceutical Co Ltd. The current atr is 0.14404121.

North China Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartNorth China Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of North China Pharmaceutical Co Ltd. The current obv is -339,801,344.

North China Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartNorth China Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of North China Pharmaceutical Co Ltd. The current mfi is 54.83.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
North China Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartNorth China Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for North China Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

North China Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of North China Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.225
Ma 20Greater thanMa 504.652
Ma 50Greater thanMa 1004.735
Ma 100Greater thanMa 2005.174
OpenGreater thanClose4.590
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of North China Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on North China Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about North China Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about North China Pharmaceutical Co Ltd

I send you an email if I find something interesting about North China Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about North China Pharmaceutical Co Ltd.

Receive notifications about North China Pharmaceutical Co Ltd in your mailbox!